| |
Abstract Oral Presentation 1 |
| |
8:30 AM-12:30 PM, March 20, 2008, Hall #2AB |
| |
|
| |
Section 1: Heart Rhythm |
| |
|
|
| |
Moderator |
Jihong Guo
Ziwen Ren
Lihua Shang |
| |
|
|
| |
8:30 AM |
Effect of RVA or RVS Pacing for Cardiac Resynchronization Therapy
(AS-0260)
Dongmei Wang, et al. |
| |
|
| |
8:40 AM |
Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Organic Heart Diseases Using CARTO Electroanatomic Mapping System and a Saline-Irrigated Tip Catheter (AS-0276)
Zulu Wang, et al. |
| |
|
|
| |
8:50 AM |
Identification of Effective Ablation Line for CARTO-Guided Substrate Modification before Energy Delivery in Patients with Ventricular Tachycardia after Myocardial Infarction (AS-0323)
Yigang Li, et al. |
| |
|
|
| |
9:00 AM |
The Analysis of Ventricular Fibrillation Happened in Fu Wai Hospital within 10 Years (AS-0587)
Jing Wang, et al. |
| |
|
|
| |
9:10 AM |
The Efficiency and Safety of Active-Fixation Pacing Leads and Right Ventricular Outflow Pacing: A Multicenter, Prospective and Randomized Study (AS-0635)
Keping Chen, et al. |
| |
|
|
| |
9:20 AM |
Q&A |
| |
|
|
| |
|
|
| |
Section 2: Peripheral Vascular and Structural Heart Disease |
| |
|
|
| |
Moderator |
Luyue Gai
Zhi Zeng
Xiangyang Fu |
| |
|
|
| |
9:30 AM |
The Problem and Challenge of Interventional Therapy of Perimembranous Ventricular Septal Defects: 5 Years Experience in Fuwai Hospital (AS-0179)
Haibo Hu, et al. |
| |
|
|
| |
9:40 AM |
Clinical Feasibility and Angiographic Follow-Up of Endovascular Stent-Graft for Type B Dissection (Stanford): Experience of a Single Center in Brazil (AS-0184)
Daige Augusto, et al. |
| |
|
|
| |
9:50 AM |
Single Center Experience of Balloon Mitral Valvuloplasty (BMV) In Pregnant Females (AS-0245)
Jayesh S. Prajpati, et al. |
| |
|
|
| |
10:00 AM |
Endovascular Repair of Type B Aortic Dissection: A Report of 78 Patients (AS-0251)
Quanmin Jing, et al. |
| |
|
|
| |
10:10 AM |
Percutaneous Implantation of Nitinol Stent for Creation of Pulmonary Regurgitation in Sheep Model (AS-0394)
Yuan Bai, et al. |
| |
|
|
| |
10:20 AM |
Q&A |
| |
|
|
| |
|
|
| |
Section 3: Coronary Artery Disease 1 |
| |
|
|
| |
Moderator |
Moderator Jilin Chen
Xiangjun Yang
Zhongjie Fan |
| |
|
|
| |
10:30 AM |
Persistent Inhibition of Neointimal Hyperplasia after FIREBIRD 2 Sirolimus-Eluting Stent Implantation: Long-Term (Up to 2 Years) Clinical, Angiographic, and Intravascular Ultrasound Follow-Up - A Single Center Experience (AS-0527)
Jie Qian, et al. |
| |
|
|
| |
10:40 AM |
Real-World Safety and Efficacy of the ENDEAVOR Zotarolimus-Eluting Stent: One-Year Clinical Outcomes in the First 2000 Patients in the E-Five Registry (AS-0306)
Damras Tresukosol, et al. |
| |
|
|
| |
10:50 AM |
A Novel Slow-Release Paclitaxel-Eluting Stent with a Bioabsorbable Polymeric Surface Coating (AS-0684)
Refat Jabara, et al. |
| |
|
|
| |
11:00 AM |
Three-Year Follow-Up of FIREBIRD Stent in Daily Practice (AS-0169)
Zhan Gao, et al. |
| |
|
|
| |
11:10 AM |
Stenting for Distal Left Main Bifurcation Lesions: Importance of DK Crush Technique (AS-0646)
Shaoliang Chen, et al. |
| |
|
|
| |
11:20 AM |
Q&A |
| |
|
|
| |
|
|
| |
Section 4: Coronary Artery Disease 2 |
| |
|
|
| |
Moderator |
Lan Huang
Shisen Jiang |
| |
|
|
| |
11:30 AM |
Prevalence and Characteristics of Myocardial Bridging in Coronary Angiogram: Clinical Data from 854 Cases (AS-0523)
Juying Qian |
| |
|
|
| |
11:40 AM |
Association between the Inflammatory Markers and IVUS in Patients with Coronary Heart Disease (AS-0555)
Jianlong Wang, et al. |
| |
|
|
| |
11:50 AM |
Comparison of Multidetector 64-Slice Computed Tomographic Angiography to Coronary Angiography to Assess the Patency of Coronary Artery Bypass Grafts (AS-0685)
Refat Jabara, et al. |
| |
|
|
| |
12:00 PM |
Role of Intravascular Ultrasound in Clinical Decision-Making for Moderate Coronary Artery Stenosis (AS-0563)
Ling Zhang, et al. |
| |
|
|
| |
12:10 PM |
Ultrasound-Guided Thrombin Injection for the Treatment of Iatrogenic Pseudoaneurysm of the Femoral Artery in 40 Cases (AS-0419)
Jincheng Guo, et al. |
| |
|
|
| |
12:20 PM |
Q&A |
| |
|
|
| |
12:30 PM |
Adjourn |
| |
|
|
